- Home
- CADL vs DRDB Comparison
CADL vs DRDB Comparison
Compare CADL & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.89
Company Overview
Basic Information| Metric | CADL | DRDB |
|---|---|---|
| Founded | 1999 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 320.8M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | CADL | DRDB |
|---|---|---|
| Price | $5.89 | $10.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 743.5K | 37.1K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $600.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $9.87 |
| 52 Week High | $13.68 | $10.55 |
Technical Indicators
Market Signals| Indicator | CADL | DRDB |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 55.34 |
| Support Level | $5.91 | $10.42 |
| Resistance Level | $6.62 | $10.55 |
| Average True Range (ATR) | 0.38 | 0.03 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 32.57 | 58.33 |
Price Performance
Historical Comparison CADL
DRDB
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.